This announcement is a separate document:
泰林生物：上海锦天城（杭州）律师事务所关于浙江泰林生物技术股份有限公司调整2022年限制性股票激励计划限制性股票数量及授予价格、作废2022年限制性股票激励计划部分已授予尚未归属的限制性股票、向激励对象授予预留限制性股票的法律意见书
Tailin Biology: Legal opinion from Shanghai Jintiancheng (Hangzhou) Law Firm on Zhejiang Tailin Biotechnology Co., Ltd. adjusting the number of restricted stocks and grant prices in the 2022 restricted stock incentive plan, abolishing part of the 2022 rest
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.